Blog
RSS FeedPosted by Michael Wonder on 11 Apr 2021
Australian Medical Association says GPs are protected when administering AstraZeneca vaccines
11 April 2021 - Australian Medical Association vice-president Chris Moy says if a patient makes an informed decision to receive the ...
Posted by Michael Wonder on 10 Apr 2021
Johnson & Johnson COVID-19 vaccine under review by EMA over blood clots
10 April 2021 - Europe’s drug regulator says it is reviewing rare blood clots in four people in the United States ...
Posted by Michael Wonder on 10 Apr 2021
Doctors stop offering AstraZeneca jabs over legal risk
11 April 2021 - Many of the nation’s GPs are refusing to offer AstraZeneca’s vaccine to people under 50 until ...
Posted by Michael Wonder on 08 Apr 2021
ATAGI statement on AstraZeneca vaccine in response to new vaccine safety concerns
8 April 2021 - A statement from the Australian Technical Advisory Group on Immunisation (ATAGI) on the AstraZeneca COVID-19 vaccine in ...
Posted by Michael Wonder on 08 Apr 2021
With millions vaccinated, rare side-effects of jabs are emerging
7 April 2021 - Sorting signal from noise. ...
Posted by Michael Wonder on 07 Apr 2021
MHRA issues new advice, concluding a possible link between COVID-19 Vaccine AstraZeneca and extremely rare, unlikely to occur blood clots
7 April 2021 - The benefits of vaccination continue to outweigh any risks but the MHRA advises careful consideration be given ...
Posted by Michael Wonder on 07 Apr 2021
AstraZeneca’s COVID-19 vaccine: EMA finds possible link to very rare cases of unusual blood clots with low blood platelets
7 April 2021 - EMA confirms overall benefit-risk remains positive. ...
Posted by Michael Wonder on 06 Apr 2021
Statement by Acting Australian Government Chief Medical Officer, Professor Michael Kidd and Head of the Therapeutic Goods Administration Adjunct Professor John Skerritt
2 April 2021 - Australia's vaccine safety and regulatory process is world class and people can be confident that vaccines ...
Posted by Michael Wonder on 31 Mar 2021
AstraZeneca COVID-19 vaccine: review of very rare cases of unusual blood clots continues
31 March 2021 - EMA’s safety committee (PRAC) is meeting today in the context of its ongoing review of very ...
Posted by Michael Wonder on 30 Mar 2021
Germany to restrict AstraZeneca use in under-60s over clots
30 March 2021 - German health officials have agreed to restrict the use of AstraZeneca’s coronavirus vaccine in people under 60, ...
Posted by Michael Wonder on 30 Mar 2021
Health Canada taking further action to confirm the benefit-risk profile of the AstraZeneca vaccine
29 March 2021 - As part of Health Canada’s continuing commitment to openness and transparency on all information relating to ...
Posted by Michael Wonder on 30 Mar 2021
Canada urges halt in use of AstraZeneca COVID-19 vaccine in people under 55
30 March 2021 - Canadian authorities recommended Monday a halt on administering the AstraZeneca PLC COVID-19 vaccine on people under ...
Posted by Michael Wonder on 25 Mar 2021
COVID-19 Vaccine AstraZeneca – update on ongoing evaluation of blood clot cases
25 March 2021 - Last week, EMA’s safety committee, PRAC, concluded its preliminary review of cases of blood clots, including very ...
Posted by Michael Wonder on 24 Mar 2021
Health Canada says AstraZeneca shot is safe as U.S. questions vaccine's clinical trial data
23 March 2021 - U.S. regulator says AstraZeneca may have included 'outdated' data when releasing clinical trial results. ...
Posted by Michael Wonder on 22 Mar 2021
ATAGI statement and clinical guidance on AstraZeneca COVID-19 vaccine following EMA safety review
19 March 2021 - This statement from the Australian Technical Advisory Group on Immunisation updates advice previous provided on 16 March. ...